Version 5.4
Bos taurus Protein: BCL9L
Summary
InnateDB Protein IDBP-683002.2
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol BCL9L
Protein Name B-cell CLL/lymphoma 9-like
Synonyms
Species Bos taurus
Ensembl Protein ENSBTAP00000006774
InnateDB Gene IDBG-631451 (BCL9L)
Protein Structure
UniProt Annotation
Function
Subcellular Localization
Disease Associations
Tissue Specificity
Comments
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 0 experimentally validated interaction(s) in this database.
They are also associated with 5 interaction(s) predicted by orthology.
Predicted by orthology
Total 5 [view]
Gene Ontology

Molecular Function
Accession GO Term
GO:0008013 beta-catenin binding
Biological Process
GO:0010718 positive regulation of epithelial to mesenchymal transition
GO:0022604 regulation of cell morphogenesis
GO:0030512 negative regulation of transforming growth factor beta receptor signaling pathway
GO:0035019 somatic stem cell maintenance
GO:0035914 skeletal muscle cell differentiation
GO:0045944 positive regulation of transcription from RNA polymerase II promoter
GO:0060070 canonical Wnt signaling pathway
Cellular Component
GO:0005634 nucleus
Protein Structure and Domains
PDB ID
InterPro IPR024670 B-cell lymphoma 9, beta-catenin binding domain
PFAM PF11502
PRINTS
PIRSF
SMART
TIGRFAMs
Post-translational Modifications
Modification
Cross-References
SwissProt
PhosphoSite PhosphoSite-
TrEMBL E1B8K0
UniProt Splice Variant
Entrez Gene 539340
UniGene Bt.111607
RefSeq NP_001192585
HUGO HGNC:23688
OMIM
CCDS
HPRD
IMGT
EMBL DAAA02040484
GenPept

If you use InnateDB for your research, please cite the following publication:

Breuer et al., InnateDB: systems biology of innate immunity and beyond - recent updates and continuing curation. Nucl. Acids Res. (2013) 41 (D1) 

InnateDB is being developed jointly by the Brinkman Laboratory (Simon Fraser University, British Columbia, Canada), the Hancock Laboratory (University of British Columbia, Vancouver, British Columbia) and the Lynn EMBL Australia Group (South Australian Health & Medical Research Institute and Flinders University, Adelaide, Australia).

Funding is currently provided by Allergen and EMBL Australia. Previous funding has been provided by Genome Canada, the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative and by Teagasc. InnateDB curated interactions are licensed under the Design Science License. All other data is licensed under the terms of the originating database. Contact: innatedb-mail@sfu.ca